Guillaume Bossis

3.8k citations
62 papers · 3.0k indexed · h-index 29
    • Ubiquitin and proteasome pathways 45
    • Histone Deacetylase Inhibitors Research 8
  • Oncology top 5%
    • Peptidase Inhibition and Analysis 13
    • Cancer-related Molecular Pathways 13
    • Endoplasmic Reticulum Stress and Disease 5
  • Immunology top 10%
    • interferon and immune responses 6
    • Virus-based gene therapy research 5
    • Acute Myeloid Leukemia Research 5

Guillaume Bossis

60 papers receiving 3.0k citations

Peers

Guillaume Bossis
Comparison fields: 5 of 110
  • Molecular Biology 2.3k
  • Oncology 727
  • Cell Biology 367
  • Cancer Research 304
  • Immunology 420
Replace Ofer Cohen with:
Ofer Cohen Israel
Mariola J. Edelmann United States
Liam O’Connor Australia
Colin Adrain United Kingdom
Xue Li China
Tencho Tenev United Kingdom
Xiao‐Bo Qiu China
Chunying Du United States
Hamish Allen United States
Noor Gammoh United Kingdom
Guillaume Bossis relative to Ofer Cohen Israel Ofer Cohen's profile →
Citations per field
00.5×1.5×
Ofer Cohen · 1×
Citations per year

Countries citing papers authored by Guillaume Bossis

Since Specialization
Citations

This map shows the geographic impact of Guillaume Bossis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume Bossis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume Bossis more than expected).

Fields of papers citing papers by Guillaume Bossis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillaume Bossis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume Bossis. The network helps show where Guillaume Bossis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guillaume Bossis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guillaume Bossis Line = papers co-authored together Guillaume Bossis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20245
2 20222
3 20227
4 202116
5 202012
6 202013
7 201948
8 201842
9 201891
10 20164
11 201344
12 201256
13 201025
14 200820
15 200855
16 200746
17 2006125
18 2005161
19 20054
20 20038

About Guillaume Bossis

Guillaume Bossis is a scholar working on Oncology, Molecular Biology and Immunology, having authored 62 papers that have together received 3.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (45 papers), Peptidase Inhibition and Analysis (13 papers), Cancer-related Molecular Pathways (13 papers), Histone Deacetylase Inhibitors Research (8 papers), interferon and immune responses (6 papers), Virus-based gene therapy research (5 papers), Acute Myeloid Leukemia Research (5 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). The work is most often cited by research in Molecular Biology (2.3k citations), Oncology (727 citations) and Cell Biology (367 citations). Guillaume Bossis has collaborated with scholars based in France, Germany and United Kingdom. Frequent co-authors include Marc Piechaczyk, Frauke Melchior, Isabelle Jariel‐Encontre, Denis Tempé, Frédérique Brockly, Claire Acquaviva, Patrizia Ferrara, Robert A. Hipskind, Manuel S. Rodríguez and Rosa Farrás. Their work appears in journals such as Cell, Angewandte Chemie International Edition and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026